COMMENTARYAccepted on 09 Jan 2026Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1Mary JC. HendrixElisabeth SeftorRichard SeftorYi-Wen ChuDu-Shieng ChienYen-Ling Chen
